Published on in Vol 5, No 3 (2016): Jul-Sept

A Cross-Sectional Comparison of Druggable Mutations in Primary Tumors, Metastatic Tissue, Circulating Tumor Cells, and Cell-Free Circulating DNA in Patients with Metastatic Breast Cancer: The MIRROR Study Protocol

A Cross-Sectional Comparison of Druggable Mutations in Primary Tumors, Metastatic Tissue, Circulating Tumor Cells, and Cell-Free Circulating DNA in Patients with Metastatic Breast Cancer: The MIRROR Study Protocol

A Cross-Sectional Comparison of Druggable Mutations in Primary Tumors, Metastatic Tissue, Circulating Tumor Cells, and Cell-Free Circulating DNA in Patients with Metastatic Breast Cancer: The MIRROR Study Protocol

Milagros Gonzalez-Rivera   1 , MD, MSc, PhD ;   Antoni C Picornell   2 , MPH, MSc, PhD ;   Enrique L Alvarez   2 , MSc ;   Miguel Martin   3 , MD, PhD

1 Gregorio Marañón Health Research Institute, Laboratory of Translational Oncology, Sequencing & Genotyping-Research Shared Resources, Gregorio Marañón General University Hospital, Madrid, Spain

2 Gregorio Marañón Health Research Institute, Department of Bioinformatics & Biostatistics, Gregorio Marañón General University Hospital, Madrid, Spain

3 Gregorio Marañón Health Research Institute, Medical Oncology Department, Gregorio Marañón General University Hospital, Madrid, Spain

Corresponding Author:

  • Milagros Gonzalez-Rivera, MD, MSc, PhD
  • Gregorio Marañón Health Research Institute
  • Laboratory of Translational Oncology, Sequencing & Genotyping-Research Shared Resources
  • Gregorio Marañón General University Hospital
  • Calle del Doctor Esquerdo 46
  • Madrid, 28007
  • Spain
  • Phone: 34 91 557 24 46
  • Fax: 34 91 586 83 94
  • Email: milagros.gonzalez@iisgm.com